Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 5/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.40 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29601221 | 1.00 | L3MBTL1 (0.46) | L3MBTL1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| Quinoline SCHEMBL28210108 | 0.84 | ALDH1A1 (0.57) | L3MBTL1ALDH1A1HSD17B10CYP1A2PDE4A | |
| Isoquinoline SCHEMBL28149933 | 0.82 | KDM4E (0.42) | L3MBTL1CYP1A2MAPTLMNACYP3A4 | |
| SCHEMBL374938 | 0.77 | ALDH1A1 (0.39) | L3MBTL1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL29091622 | 0.77 | L3MBTL1 (0.43) | L3MBTL1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL23860797 | 0.77 | F12 (0.47) | L3MBTL1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL2170888 | 0.77 | CYP2A6 (0.47) | L3MBTL1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL30544379 | 0.77 | L3MBTL1 (0.50) | L3MBTL1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL7882102 | 0.77 | TRPM4 (0.45) | L3MBTL1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL3083764 | 0.77 | TRPM4 (0.45) | L3MBTL1ALDH1A1HSD17B10HIF1ACYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 667 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107126760-A | A kind of ceramic grain filter and its preparation method and application | 徐州工程学院 | 2017-09-05 | — | — | CN | claimed |
| CN-100534986-C | Method for preparing derivative of 1,4 - dichloro isoquinoline category | UNIV ZHEJIANG POLYTECHNIC (CN) | 2009-09-02 | — | — | CN | claimed |
| CN-101092395-A | Method for preparing derivative of 1,4 - dichloro isoquinoline category | UNIV ZHEJIANG POLYTECHNIC (CN) | 2007-12-26 | — | — | CN | claimed |
| US-5939568-A | Accelerated catalysis of olefinic epoxidations | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-08-17 | — | — | US | claimed |
| WO-1998033786-A9 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | — | 1998-12-30 | — | — | WO | claimed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | claimed |
| US-12617791-B2 | Triheterocyclic derivative, and pharmaceutical composition and application thereof | Shanghai De Novo Pharmatech Co., Ltd. (CN) | 2026-05-05 | — | — | US | disclosed |
| EP-4142732-B1 | METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS | GLOBAL BLOOD THERAPEUTICS INC (US) | 2026-04-22 | — | — | EP | disclosed |
| US-12570671-B2 | Substituted oxoisoindoline compounds for the treatment of cancer | BRISTOL-MYERS SQUIBB COMPANY (US) | 2026-03-10 | — | — | US | disclosed |
| EP-4126843-B1 | SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER | BRISTOL MYERS SQUIBB CO (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2025235957-A1 | P53 MUTANT STABILIZER AND USES THEREOF | FRONTIER MEDICINES CORPORATION (US) | 2025-11-13 | — | — | WO | disclosed |
| EP-4230628-B1 | TRIHETEROCYCLIC DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | SHANGHAI DE NOVO PHARMATECH CO LTD (CN) | 2025-10-15 | — | — | EP | disclosed |
| WO-2025073554-A2 | PARP1 INHIBITOR COMPOUNDS | Duke Street Bio Limited (GB) | 2025-04-10 | — | — | WO | disclosed |
| EP-0317188-B1 | Heteroaromatic enamide derivatives and their use as pesticides | ROUSSEL UCLAF (FR) | 1995-09-27 | — | — | EP | disclosed |
| US-5114940-A | Insecticides or anthelmintics from fused ring heterocycles containing amides or thioamides | ROUSSEL-UCLAF (FR) | 1992-05-19 | — | — | US | disclosed |
| EP-0317188-A2 | Heteroaromatic enamide derivatives and their use as pesticides | ROUSSEL UCLAF (FR) | 1989-05-24 | — | — | EP | disclosed |
| EP-0048539-B1 | ISOQUINOLYLOXY(AMINO)PHENOXYALKANE CARBOXYLIC ACID DERIVATIVES, PROCESS FOR THEIR SYNTHESIS, HERBICIDAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS HERBICIDES | ICI AUSTRALIA LIMITED (AU) | 1985-08-28 | — | — | EP | disclosed |
| US-4409017-A | Herbicidal isoquinolinoxy- or isoquinolinamino-phenoxy alkane carboxylic acid derivatives | ICI AUSTRALIA LIMITED (AU) | 1983-10-11 | — | — | US | disclosed |
| EP-0048539-A1 | Isoquinolyloxy(amino)phenoxyalkane carboxylic acid derivatives, process for their synthesis, herbicidal compositions containing them and their use as herbicides | ICI AUSTRALIA LIMITED (AU) | 1982-03-31 | — | — | EP | disclosed |
| US-3975524-A | ANTICOAGULANTS | BOEHRINGER INGELHEIM GMBH (DT) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570671-B2 | Substituted oxoisoindoline compounds for the treatment of cancer | NR3C1, NR2C2, RIOX2 | L3MBTL1 2925/4885ALDH1A1 3404/4885HSD17B10 2828/4885 |
| US-12617791-B2 | Triheterocyclic derivative, and pharmaceutical composition and application thereof | ATR, NR3C1, NR5A1 | L3MBTL1 3277/4885ALDH1A1 3465/4885HSD17B10 1962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.